centrotherm international AG (CTNK) - Cash Flow Conversion Efficiency

Latest as of June 2023: 0.144x

Based on the latest financial reports, centrotherm international AG (CTNK) has a cash flow conversion efficiency ratio of 0.144x as of June 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€8.39 Million ≈ $9.80 Million USD) by net assets (€58.15 Million ≈ $67.99 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

centrotherm international AG - Cash Flow Conversion Efficiency Trend (2006–2024)

This chart illustrates how centrotherm international AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read centrotherm international AG (CTNK) total liabilities for a breakdown of total debt and financial obligations.

centrotherm international AG Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of centrotherm international AG ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Humacyte Inc
NASDAQ:HUMA
5.031x
SAB Biotherapeutics Inc
NASDAQ:SABS
-0.079x
Socovesa
SN:SOCOVESA
-0.126x
Teladan Setia Group Bhd
KLSE:0230
0.033x
Vieworks Co. Ltd
KQ:100120
0.076x
PHX Minerals Inc
NYSE:PHX
0.034x
Rent the Runway Inc
NASDAQ:RENT
0.040x
Thai Rayon Public Company Limited
BK:TR
-0.018x

Annual Cash Flow Conversion Efficiency for centrotherm international AG (2006–2024)

The table below shows the annual cash flow conversion efficiency of centrotherm international AG from 2006 to 2024. For the full company profile with market capitalisation and key ratios, see market value of centrotherm international AG.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €109.34 Million
≈ $127.83 Million
€50.48 Million
≈ $59.02 Million
0.462x +468.92%
2023-12-31 €83.20 Million
≈ $97.27 Million
€-10.41 Million
≈ $-12.17 Million
-0.125x -122.89%
2022-12-31 €55.40 Million
≈ $64.77 Million
€30.28 Million
≈ $35.41 Million
0.547x +148.40%
2021-12-31 €43.73 Million
≈ $51.12 Million
€9.62 Million
≈ $11.25 Million
0.220x -38.04%
2020-12-31 €31.86 Million
≈ $37.24 Million
€11.31 Million
≈ $13.23 Million
0.355x +365.08%
2019-12-31 €41.75 Million
≈ $48.81 Million
€-5.59 Million
≈ $-6.54 Million
-0.134x +24.01%
2018-12-31 €57.87 Million
≈ $67.66 Million
€-10.20 Million
≈ $-11.93 Million
-0.176x -4.40%
2017-12-31 €55.94 Million
≈ $65.40 Million
€-9.45 Million
≈ $-11.05 Million
-0.169x +57.11%
2016-12-31 €44.18 Million
≈ $51.65 Million
€-17.40 Million
≈ $-20.34 Million
-0.394x -607.63%
2015-12-31 €50.30 Million
≈ $58.80 Million
€-2.80 Million
≈ $-3.27 Million
-0.056x -115.63%
2014-12-31 €43.11 Million
≈ $50.40 Million
€15.35 Million
≈ $17.95 Million
0.356x +291.28%
2011-12-31 €366.08 Million
≈ $427.99 Million
€-68.16 Million
≈ $-79.68 Million
-0.186x -206.26%
2010-12-31 €396.36 Million
≈ $463.38 Million
€69.44 Million
≈ $81.19 Million
0.175x +21.37%
2009-12-31 €344.44 Million
≈ $402.69 Million
€49.72 Million
≈ $58.13 Million
0.144x -29.39%
2008-12-31 €318.19 Million
≈ $372.00 Million
€65.05 Million
≈ $76.05 Million
0.204x +9.01%
2007-12-31 €161.46 Million
≈ $188.76 Million
€30.28 Million
≈ $35.40 Million
0.188x +620.38%
2006-12-31 €6.91 Million
≈ $8.08 Million
€-249.00K
≈ $-291.11K
-0.036x --

About centrotherm international AG

F:CTNK Germany Semiconductors
Market Cap
$291.94 Million
€249.72 Million EUR
Market Cap Rank
#17248 Global
#1622 in Germany
Share Price
€11.80
Change (1 day)
+0.00%
52-Week Range
€3.80 - €13.00
All Time High
€13.00
About

centrotherm international AG provides production equipment and solutions for the photovoltaic, semiconductor, and microelectronic industries worldwide. It offers low pressure diffusion furnace, plasma enhanced chemical vapor deposition and LPCVD systems, fast firing furnaces, regeneration furnaces, and batch-type systems; integrated production solutions for the manufacturing of mono and multi-cry… Read more